Press Release BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ 12 hours ago
Press Release BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer Aug 5